188 related articles for article (PubMed ID: 32444843)
1. The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility.
Mohammadi A; Bagherichimeh S; Perry MC; Fazel A; Tevlin E; Huibner S; Tharao W; Coburn B; Kaul R
Sci Rep; 2020 May; 10(1):8514. PubMed ID: 32444843
[TBL] [Abstract][Full Text] [Related]
2. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R
Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498
[TBL] [Abstract][Full Text] [Related]
3. Distinct Effects of the Cervicovaginal Microbiota and Herpes Simplex Type 2 Infection on Female Genital Tract Immunology.
Shannon B; Gajer P; Yi TJ; Ma B; Humphrys MS; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Shahabi K; Ravel J; Kaul R
J Infect Dis; 2017 May; 215(9):1366-1375. PubMed ID: 28201724
[TBL] [Abstract][Full Text] [Related]
4. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
[TBL] [Abstract][Full Text] [Related]
5. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women.
Reimers LL; Mehta SD; Massad LS; Burk RD; Xie X; Ravel J; Cohen MH; Palefsky JM; Weber KM; Xue X; Anastos K; Minkoff H; Atrio J; D'Souza G; Ye Q; Colie C; Zolnik CP; Spear GT; Strickler HD
J Infect Dis; 2016 Nov; 214(9):1361-1369. PubMed ID: 27521363
[TBL] [Abstract][Full Text] [Related]
6. Bacterial Vaginosis Is Associated with Loss of Gamma Delta T Cells in the Female Reproductive Tract in Women in the Miami Women Interagency HIV Study (WIHS): A Cross Sectional Study.
Alcaide ML; Strbo N; Romero L; Jones DL; Rodriguez VJ; Arheart K; Martinez O; Bolivar H; Podack ER; Fischl MA
PLoS One; 2016; 11(4):e0153045. PubMed ID: 27078021
[TBL] [Abstract][Full Text] [Related]
7. HIV susceptibility in women: The roles of genital inflammation, sexually transmitted infections and the genital microbiome.
Mtshali A; Ngcapu S; Mindel A; Garrett N; Liebenberg L
J Reprod Immunol; 2021 Jun; 145():103291. PubMed ID: 33647576
[TBL] [Abstract][Full Text] [Related]
8. Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators.
Dezzutti CS; Hendrix CW; Marrazzo JM; Pan Z; Wang L; Louissaint N; Kalyoussef S; Torres NM; Hladik F; Parikh U; Mellors J; Hillier SL; Herold BC
PLoS One; 2011; 6(8):e23136. PubMed ID: 21858008
[TBL] [Abstract][Full Text] [Related]
9. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
Kyongo JK; Crucitti T; Menten J; Hardy L; Cools P; Michiels J; Delany-Moretlwe S; Mwaura M; Ndayisaba G; Joseph S; Fichorova R; van de Wijgert J; Vanham G; Ariën KK; Jespers V
Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460
[TBL] [Abstract][Full Text] [Related]
10. Bacterial vaginosis and the cervicovaginal immune response.
Mitchell C; Marrazzo J
Am J Reprod Immunol; 2014 Jun; 71(6):555-63. PubMed ID: 24832618
[TBL] [Abstract][Full Text] [Related]
11. The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH).
Nikolaitchouk N; Andersch B; Falsen E; Strömbeck L; Mattsby-Baltzer I
APMIS; 2008 Apr; 116(4):263-77. PubMed ID: 18397461
[TBL] [Abstract][Full Text] [Related]
12. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age.
Fichorova RN; Morrison CS; Chen PL; Yamamoto HS; Govender Y; Junaid D; Ryan S; Kwok C; Chipato T; Salata RA; Doncel GF
PLoS One; 2020; 15(1):e0224359. PubMed ID: 31914129
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study.
Masson L; Barnabas S; Deese J; Lennard K; Dabee S; Gamieldien H; Jaumdally SZ; Williamson AL; Little F; Van Damme L; Ahmed K; Crucitti T; Abdellati S; Bekker LG; Gray G; Dietrich J; Jaspan H; Passmore JS
Sex Transm Infect; 2019 Feb; 95(1):5-12. PubMed ID: 30018088
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory and antimicrobial properties differ between vaginal Lactobacillus isolates from South African women with non-optimal versus optimal microbiota.
Manhanzva MT; Abrahams AG; Gamieldien H; Froissart R; Jaspan H; Jaumdally SZ; Barnabas SL; Dabee S; Bekker LG; Gray G; Passmore JS; Masson L
Sci Rep; 2020 Apr; 10(1):6196. PubMed ID: 32277092
[TBL] [Abstract][Full Text] [Related]
15. Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women.
Mngomezulu K; Mzobe GF; Mtshali A; Osman F; Liebenberg LJP; Garrett N; Singh R; Rompalo A; Mindel A; Karim SSA; Karim QA; Baxter C; Ngcapu S
Front Immunol; 2021; 12():695201. PubMed ID: 34177961
[TBL] [Abstract][Full Text] [Related]
16. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis.
Hoang T; Toler E; DeLong K; Mafunda NA; Bloom SM; Zierden HC; Moench TR; Coleman JS; Hanes J; Kwon DS; Lai SK; Cone RA; Ensign LM
PLoS Pathog; 2020 Jan; 16(1):e1008236. PubMed ID: 31971984
[TBL] [Abstract][Full Text] [Related]
17. Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with Chlamydia trachomatis infection: a pilot study.
Sperling R; Kraus TA; Ding J; Veretennikova A; Lorde-Rollins E; Singh T; Lo Y; Quayle AJ; Chang TL
J Reprod Immunol; 2013 Sep; 99(1-2):80-7. PubMed ID: 23993451
[TBL] [Abstract][Full Text] [Related]
18. Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota.
Shannon B; Yi TJ; Perusini S; Gajer P; Ma B; Humphrys MS; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Shahabi K; Ravel J; Rebbapragada A; Kaul R
Mucosal Immunol; 2017 Sep; 10(5):1310-1319. PubMed ID: 28120845
[TBL] [Abstract][Full Text] [Related]
19. Cervicovaginal cytokines, sialidase activity and bacterial load in reproductive-aged women with intermediate vaginal flora.
Santos-Greatti MMV; da Silva MG; Ferreira CST; Marconi C
J Reprod Immunol; 2016 Nov; 118():36-41. PubMed ID: 27620141
[TBL] [Abstract][Full Text] [Related]
20. Comparison of vaginal microbiota sampling techniques: cytobrush versus swab.
Mitra A; MacIntyre DA; Mahajan V; Lee YS; Smith A; Marchesi JR; Lyons D; Bennett PR; Kyrgiou M
Sci Rep; 2017 Aug; 7(1):9802. PubMed ID: 28852043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
